Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318941312> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4318941312 abstract "Abstract Background Mifepristone, also known as RU-486, is an anti-progestational steroid with similar chemical structure to anabolic steroids. Given as a single dose in conjunction with misoprostol, mifepristone is used to induce medical abortion. Mifepristone administered chronically at a higher dose is also approved for the management of hypercortisolism. There have been only 2 reported cases of mifepristone associated liver injury, in both cases, in the setting of Cushing syndrome. We report a third patient with Cushing syndrome with mifepristone induced liver injury with unique histological findings that provide insight to the pathophysiology of liver injury in mifepristone and anabolic steroids. Case presentation Patient is a 63-year-old Caucasian female Cushing disease with no prior history of liver disease. She was started on mifepristone and semaglutide. Ninety days after initiating mifepristone, she developed deep jaundice, severe pruritus, fatigue, and nausea. Liver tests revealed a mixed hepatocellular/cholestatic pattern. Viral and autoimmune serologies were negative and there was no biliary dilatation on imaging. Liver biopsy showed severe cholestasis but no bile duct injury. Focal endothelialitis was present within a central venule. Cholestatic symptoms persisted for one month after presentation before slowly subsiding. Four months after stopping mifepristone, the patient’s symptoms completely resolved, and liver tests became normal. Compilation of Roussell Uclaf Causality Assessment Method score indicated probable causality. Conclusions Mifepristone shares a similar chemical structure as synthetic anabolic/androgenic steroids and there are many similarities in the clinical presentation of liver injury. This case and the 2 other reported cases share similar clinical characteristics. The observation of endothelialitis in our patient may provide a mechanistic link between mifepristone, or anabolic steroids in general, and the development of vascular complications such as peliosis." @default.
- W4318941312 created "2023-02-03" @default.
- W4318941312 creator A5002170759 @default.
- W4318941312 creator A5018403835 @default.
- W4318941312 creator A5021248078 @default.
- W4318941312 creator A5049343542 @default.
- W4318941312 creator A5089349185 @default.
- W4318941312 date "2023-02-03" @default.
- W4318941312 modified "2023-10-18" @default.
- W4318941312 title "Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature" @default.
- W4318941312 cites W2049275648 @default.
- W4318941312 cites W2062487385 @default.
- W4318941312 cites W2165788910 @default.
- W4318941312 cites W2218985750 @default.
- W4318941312 cites W2566195587 @default.
- W4318941312 cites W2801064741 @default.
- W4318941312 cites W2903996854 @default.
- W4318941312 cites W2928700601 @default.
- W4318941312 cites W2973332410 @default.
- W4318941312 cites W2998718316 @default.
- W4318941312 cites W3005191572 @default.
- W4318941312 cites W3207259467 @default.
- W4318941312 cites W41862646 @default.
- W4318941312 cites W4220972902 @default.
- W4318941312 cites W74340424 @default.
- W4318941312 doi "https://doi.org/10.1186/s13256-022-03696-x" @default.
- W4318941312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36732814" @default.
- W4318941312 hasPublicationYear "2023" @default.
- W4318941312 type Work @default.
- W4318941312 citedByCount "1" @default.
- W4318941312 countsByYear W43189413122023 @default.
- W4318941312 crossrefType "journal-article" @default.
- W4318941312 hasAuthorship W4318941312A5002170759 @default.
- W4318941312 hasAuthorship W4318941312A5018403835 @default.
- W4318941312 hasAuthorship W4318941312A5021248078 @default.
- W4318941312 hasAuthorship W4318941312A5049343542 @default.
- W4318941312 hasAuthorship W4318941312A5089349185 @default.
- W4318941312 hasBestOaLocation W43189413121 @default.
- W4318941312 hasConcept C126322002 @default.
- W4318941312 hasConcept C2776106523 @default.
- W4318941312 hasConcept C2776637226 @default.
- W4318941312 hasConcept C2778456037 @default.
- W4318941312 hasConcept C2778826759 @default.
- W4318941312 hasConcept C2779234561 @default.
- W4318941312 hasConcept C54355233 @default.
- W4318941312 hasConcept C71924100 @default.
- W4318941312 hasConcept C86803240 @default.
- W4318941312 hasConcept C90924648 @default.
- W4318941312 hasConceptScore W4318941312C126322002 @default.
- W4318941312 hasConceptScore W4318941312C2776106523 @default.
- W4318941312 hasConceptScore W4318941312C2776637226 @default.
- W4318941312 hasConceptScore W4318941312C2778456037 @default.
- W4318941312 hasConceptScore W4318941312C2778826759 @default.
- W4318941312 hasConceptScore W4318941312C2779234561 @default.
- W4318941312 hasConceptScore W4318941312C54355233 @default.
- W4318941312 hasConceptScore W4318941312C71924100 @default.
- W4318941312 hasConceptScore W4318941312C86803240 @default.
- W4318941312 hasConceptScore W4318941312C90924648 @default.
- W4318941312 hasIssue "1" @default.
- W4318941312 hasLocation W43189413121 @default.
- W4318941312 hasLocation W43189413122 @default.
- W4318941312 hasLocation W43189413123 @default.
- W4318941312 hasOpenAccess W4318941312 @default.
- W4318941312 hasPrimaryLocation W43189413121 @default.
- W4318941312 hasRelatedWork W2006973392 @default.
- W4318941312 hasRelatedWork W2059069291 @default.
- W4318941312 hasRelatedWork W2291036311 @default.
- W4318941312 hasRelatedWork W2350922817 @default.
- W4318941312 hasRelatedWork W2372512466 @default.
- W4318941312 hasRelatedWork W2376383948 @default.
- W4318941312 hasRelatedWork W2396046574 @default.
- W4318941312 hasRelatedWork W2966571955 @default.
- W4318941312 hasRelatedWork W4255676631 @default.
- W4318941312 hasRelatedWork W57558160 @default.
- W4318941312 hasVolume "17" @default.
- W4318941312 isParatext "false" @default.
- W4318941312 isRetracted "false" @default.
- W4318941312 workType "article" @default.